DOCSLIB.ORG

TOM1L1 Drives Membrane Delivery of MT1-MMP to Promote ERBB2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TOM1L1 Drives Membrane Delivery of MT1-MMP to Promote ERBB2 TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion Clément Chevalier, Guillaume Collin, Simon Descamps, Heiani Touaitahuata, Valérie Simon, Nicolas Reymond, Laurent Fernandez, Pierre-Emmanuel Milhiet, Virginie Georget, Serge Urbach, et al. To cite this version: Clément Chevalier, Guillaume Collin, Simon Descamps, Heiani Touaitahuata, Valérie Simon, et al.. TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast can- cer cell invasion. Nature Communications, Nature Publishing Group, 2016, 7 (1), pp.10765. 10.1038/ncomms10765. hal-01299292 HAL Id: hal-01299292 https://hal-univ-rennes1.archives-ouvertes.fr/hal-01299292 Submitted on 8 Jun 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License ARTICLE Received 3 Mar 2015 | Accepted 19 Jan 2016 | Published 22 Feb 2016 DOI: 10.1038/ncomms10765 OPEN TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion Cle´ment Chevalier1,*,w, Guillaume Collin1,*,w, Simon Descamps1, Heiani Touaitahuata1, Vale´rie Simon1, Nicolas Reymond1, Laurent Fernandez2, Pierre-Emmanuel Milhiet2, Virginie Georget3, Serge Urbach4, Laurence Lasorsa5,Be´atrice Orsetti5, Florence Boissie`re-Michot6, Evelyne Lopez-Crapez6, Charles Theillet5, Serge Roche1 & Christine Benistant1,2 ERBB2 overexpression in human breast cancer leads to invasive carcinoma but the mechanism is not clearly understood. Here we report that TOM1L1 is co-amplified with ERBB2 and defines a subgroup of HER2 þ /ER þ tumours with early metastatic relapse. TOM1L1 encodes a GAT domain-containing trafficking protein and is a SRC substrate that negatively regulates tyrosine kinase signalling. We demonstrate that TOM1L1 upregulation enhances the invasiveness of ERBB2-transformed cells. This pro-tumoural function does not involve SRC, but implicates membrane-bound membrane-type 1 MMP (MT1-MMP)-dependent activation of invadopodia, membrane protrusions specialized in extracellular matrix degradation. Mechanistically, ERBB2 elicits the indirect phosphorylation of TOM1L1 on Ser321. The phosphorylation event promotes GAT-dependent association of TOM1L1 with the sorting protein TOLLIP and trafficking of the metalloprotease MT1-MMP from endocytic compartments to invadopodia for tumour cell invasion. Collectively, these results show that TOM1L1 is an important element of an ERBB2-driven proteolytic invasive programme and that TOM1L1 amplification potentially enhances the metastatic progression of ERBB2-positive breast cancers. 1 Montpellier University, Centre de Recherche de Biochimie Macromole´culaire, CNRS UMR 5237, 34293 Montpellier, France. 2 Centre de Biochimie Structurale, CNRS UMR 5048-INSERM UMR 1054, 29 rue de navacelles, 34090 Montpellier, France. 3 Montpellier RIO Imaging Facility, 34293 Montpellier, France. 4 Functional Proteomics Platform, 34090 Montpellier, France. 5 IRCM, Institut de Recherche en Cance´rologie de Montpellier; INSERM U896, 34298 Montpellier, France. 6 Translational Research Unit, Institut re´gional du Cancer de Montpellier (ICM)-Val d’Aurelle, 34298 Montpellier, France. * These authors contributed equally to this work. w Present addresses: SFR Biosit, CNRS UMS 3480/INSERM US 018, MRic photonics platform, University Rennes 1, 35043 Rennes, France (C.C.); Centre de Recherche en Cance´rologie de Lyon, Inserm UMR-S1052, 69373 Lyon, France (G.C.). Correspondence and requests for materials should be addressed to S.R. (email: [email protected]) or to C.B. (email: [email protected]). NATURE COMMUNICATIONS | 7:10765 | DOI: 10.1038/ncomms10765 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10765 enetic and epigenetic alterations in breast cancer cells GRB2, p85 and members of the SRC family22,23. TOM1L1 eventually result in invasive carcinoma. The ERBB2 participates in EGFR endocytosis for lysosomal degradation Goncogene (also known as HER2 or neu), which encodes through a SRC-dependent and CHC-dependent mechanism24.It a tyrosine kinase receptor of the EGFR family, is amplified and also associates with CHC to regulate SRC membrane partitioning overexpressed in about 20% of breast tumours. Overexpressed required for SRC mitogenic and transforming activity25.In ERBB2 is abnormally concentrated at the plasma membrane, contrast with the observations in human breast cancer, in promoting receptor homo-dimerization or hetero-dimerization transgenic mice, Srcasm inhibits Fyn-induced neoplasia via kinase with additional members of the EGFR family. Dimerized downregulation and modulation of p53 and Notch. All this data receptors display strong kinase activity and induce oncogenic support a model in which TOM1L1 engages a SRC-like- signalling, leading to malignant cell transformation1. ERBB2 dependent mechanism to control tyrosine kinase signalling22–25. oncogenic potential and cell surface availability have led to Here we addressed the contribution of TOM1L1-ERBB2 the development of targeted anti-ERBB2 antibodies, such as co-amplification in ERBB2 oncogenic signalling. We show that trastuzumab (Herceptin) that has become the standard care for their co-amplification is associated with worse prognosis in patients with ERBB2-positive breast cancer. However, 50% of patients with oestrogen receptor-positive (ER þ ) breast cancer. these patients respond poorly and/or develop tumour resistance We next demonstrate that TOM1L1 enhances ERBB2-induced or show strong adverse side effects. Therefore, there is an urgent cell invasiveness by promoting invadopodia formation and need to better understand the molecular basis of ERBB2-induced MT1-MMP trafficking to the plasma membrane. This process is metastatic malignancy for developing new targeted treatments. independent from SRC activity, but requires TOM1L1 phosphor- The mechanism by which abnormal ERBB2 expression leads ylation on Ser321 and association with TOLLIP. Thus, TOM1L1 to metastatic progression is only partially elucidated. Several is an important element of an ERBB2-driven proteolytic invasive components of the invasive programme driven by ERBB2 have programme and TOM1L1 amplification potentially enhances the been identified and include the transmembrane proteins Integrin metastatic progression of ERBB2-positive breast cancers. beta 4 (ref. 2) and PlexinB1 (ref. 3), small GTPases of the Rho family4,5, microtubules, ACF7 and Memo6,7, miR-21 (ref. 8) and 9 Results the protein kinase HUNK . ERBB2-mediated invasion is also TOM1L1 is co-expressed with ERBB2 in breast cancer. We first strongly coupled to the capacity of tumour cells to induce confirmed that in breast cancer, the ERBB2 locus at 17q12 extracellular matrix (ECM) proteolysis through the activation (37.85 Mb) is frequently co-amplified with loci located at 17q22 of urokinase plasminogen activator, lysosomal cathepsins (53 Mb) and 17q23 (Fig. 1a)18. Analysis of a set of 402 breast and multi-domain zinc-dependent endopeptidases or matrix tumours showed that TOM1L1 was the most frequently metalloproteases (MMPs)10–12. Interestingly, membrane-bound co-amplified gene with ERBB2 in the 17q22-q23 region membrane-type 1 MMP (MT1-MMP) has emerged as a crucial (Supplementary Table 1). TOM1L1 gene amplification was inducer of tissue invasion and is involved in the rupturing of associated with TOM1L1 transcript upregulation (Supplementary basement membranes by tumour cells and also in cell invasion Table 2). Moreover, in breast cancer samples, TOM1L1 protein through interstitial tissues rich in type-I collagen13. MT1-MMP expression, assessed by immunohistochemistry (IHC) (Fig. 1b), invasive function is tightly controlled through intracellular was significantly associated with both ER (P ¼ 0.027) and ERBB2 trafficking and catalytic activity14. For instance, MT1-MMP is (P ¼ 0.001) expression (Fig. 1c and Supplementary Table 3). activated by proteolytic cleavage in the trans-Golgi network and Similarly, TOM1L1 protein level evaluated by western blotting partitioned in specialized membrane domains called invadopodia. was high in five out of seven ERBB2 þ cell lines, whereas it was These F-actin-enriched structures secrete proteases at cell-ECM 15,16 absent or lower in the five ERBB2-negative cell lines we tested contact sites for matrix degradation and cell invasion . (Fig. 1d). Finally, metastasis-free survival was reduced in patients Yet, the role of MT1-MMP and invadopodia activity in ERBB2- with ERBB2 þ /ER þ breast cancer in which TOM1L1 was also induced cell invasion is largely unknown. amplified compared with those without TOM1L1 amplification Target of MYB1-like protein 1 (TOM1L1, also known as (patients selected from our previous work26) (Fig. 1e). These Srcasm) has been recently identified as a gene relevant to bone results suggest a cooperative effect of ERBB2 and TOM1L1 metastasis in breast cancer17 and we observed that TOM1L1, in ER þ breast tumours and a positive role for TOM1L1 in which is located on chromosome 17q22, is frequently co-
Load more

Recommended publications
  • Extensive Rewiring of Epithelial-Stromal Co-Expression Networks in Breast Cancer
    Extensive rewiring of epithelial-stromal co-expression networks in breast cancer The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Oh, E., S. M. Christensen, S. Ghanta, J. C. Jeong, O. Bucur, B. Glass, L. Montaser-Kouhsari, et al. 2015. “Extensive rewiring of epithelial-stromal co-expression networks in breast cancer.” Genome Biology 16 (1): 128. doi:10.1186/s13059-015-0675-4. http:// dx.doi.org/10.1186/s13059-015-0675-4. Published Version doi:10.1186/s13059-015-0675-4 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295769 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Extensive rewiring of epithelial-stromal co-expression networks in breast cancer Oh et al. Oh et al. Genome Biology (2015) 16:128 DOI 10.1186/s13059-015-0675-4 Oh et al. Genome Biology (2015) 16:128 DOI 10.1186/s13059-015-0675-4 RESEARCH Open Access Extensive rewiring of epithelial-stromal co-expression networks in breast cancer Eun-Yeong Oh1,2,3†, Stephen M Christensen1,2,3†, Sindhu Ghanta1,2,3†, Jong Cheol Jeong1,2,3†, Octavian Bucur1,2,3, Benjamin Glass1,2,3, Laleh Montaser-Kouhsari1,2,3, Nicholas W Knoblauch1,2,3, Nicholas Bertos4, Sadiq MI Saleh4, Benjamin Haibe-Kains5,6, Morag Park4 and Andrew H Beck1,2,3* Abstract Background: Epithelial-stromal crosstalk plays a critical role in invasive breast cancer pathogenesis; however, little is known on a systems level about how epithelial-stromal interactions evolve during carcinogenesis.
    [Show full text]
  • Based on Network Pharmacology and RNA Sequencing Techniques to Explore the Molecular Mechanism of Huatan Jiangzhuo Decoction for Treating Hyperlipidemia
    Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2021, Article ID 9863714, 16 pages https://doi.org/10.1155/2021/9863714 Research Article Based on Network Pharmacology and RNA Sequencing Techniques to Explore the Molecular Mechanism of Huatan Jiangzhuo Decoction for Treating Hyperlipidemia XiaowenZhou ,1 ZhenqianYan ,1 YaxinWang ,1 QiRen ,1 XiaoqiLiu ,2 GeFang ,3 Bin Wang ,4 and Xiantao Li 1 1Laboratory of TCM Syndrome Essence and Objectification, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China 2Guangzhou Sagene Tech Co., Ltd., Guangzhou 510006, China 3College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China 4Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518000, China Correspondence should be addressed to Xiantao Li; [email protected] Received 22 May 2020; Revised 12 March 2021; Accepted 18 March 2021; Published 12 April 2021 Academic Editor: Jianbo Wan Copyright © 2021 Xiaowen Zhou et al. +is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Hyperlipidemia, due to the practice of unhealthy lifestyles of modern people, has been a disturbance to a large portion of population worldwide. Recently, several scholars have turned their attention to Chinese medicine (CM) to seek out a lipid-lowering approach with high efficiency and low toxicity. +is study aimed to explore the mechanism of Huatan Jiangzhuo decoction (HTJZD, a prescription of CM) in the treatment of hyperlipidemia and to determine the major regulation pathways and potential key targets involved in the treatment process.
    [Show full text]
  • Supplementary Information – Postema Et Al., the Genetics of Situs Inversus Totalis Without Primary Ciliary Dyskinesia
    1 Supplementary information – Postema et al., The genetics of situs inversus totalis without primary ciliary dyskinesia Table of Contents: Supplementary Methods 2 Supplementary Results 5 Supplementary References 6 Supplementary Tables and Figures Table S1. Subject characteristics 9 Table S2. Inbreeding coefficients per subject 10 Figure S1. Multidimensional scaling to capture overall genomic diversity 11 among the 30 study samples Table S3. Significantly enriched gene-sets under a recessive mutation model 12 Table S4. Broader list of candidate genes, and the sources that led to their 13 inclusion Table S5. Potential recessive and X-linked mutations in the unsolved cases 15 Table S6. Potential mutations in the unsolved cases, dominant model 22 2 1.0 Supplementary Methods 1.1 Participants Fifteen people with radiologically documented SIT, including nine without PCD and six with Kartagener syndrome, and 15 healthy controls matched for age, sex, education and handedness, were recruited from Ghent University Hospital and Middelheim Hospital Antwerp. Details about the recruitment and selection procedure have been described elsewhere (1). Briefly, among the 15 people with radiologically documented SIT, those who had symptoms reminiscent of PCD, or who were formally diagnosed with PCD according to their medical record, were categorized as having Kartagener syndrome. Those who had no reported symptoms or formal diagnosis of PCD were assigned to the non-PCD SIT group. Handedness was assessed using the Edinburgh Handedness Inventory (EHI) (2). Tables 1 and S1 give overviews of the participants and their characteristics. Note that one non-PCD SIT subject reported being forced to switch from left- to right-handedness in childhood, in which case five out of nine of the non-PCD SIT cases are naturally left-handed (Table 1, Table S1).
    [Show full text]
  • Supplementary Data
    Supplemental figures Supplemental figure 1: Tumor sample selection. A total of 98 thymic tumor specimens were stored in Memorial Sloan-Kettering Cancer Center tumor banks during the study period. 64 cases corresponded to previously untreated tumors, which were resected upfront after diagnosis. Adjuvant treatment was delivered in 7 patients (radiotherapy in 4 cases, cyclophosphamide- doxorubicin-vincristine (CAV) chemotherapy in 3 cases). 34 tumors were resected after induction treatment, consisting of chemotherapy in 16 patients (cyclophosphamide-doxorubicin- cisplatin (CAP) in 11 cases, cisplatin-etoposide (PE) in 3 cases, cisplatin-etoposide-ifosfamide (VIP) in 1 case, and cisplatin-docetaxel in 1 case), in radiotherapy (45 Gy) in 1 patient, and in sequential chemoradiation (CAP followed by a 45 Gy-radiotherapy) in 1 patient. Among these 34 patients, 6 received adjuvant radiotherapy. 1 Supplemental Figure 2: Amino acid alignments of KIT H697 in the human protein and related orthologs, using (A) the Homologene database (exons 14 and 15), and (B) the UCSC Genome Browser database (exon 14). Residue H697 is highlighted with red boxes. Both alignments indicate that residue H697 is highly conserved. 2 Supplemental Figure 3: Direct comparison of the genomic profiles of thymic squamous cell carcinomas (n=7) and lung primary squamous cell carcinomas (n=6). (A) Unsupervised clustering analysis. Gains are indicated in red, and losses in green, by genomic position along the 22 chromosomes. (B) Genomic profiles and recurrent copy number alterations in thymic carcinomas and lung squamous cell carcinomas. Gains are indicated in red, and losses in blue. 3 Supplemental Methods Mutational profiling The exonic regions of interest (NCBI Human Genome Build 36.1) were broken into amplicons of 500 bp or less, and specific primers were designed using Primer 3 (on the World Wide Web for general users and for biologist programmers (see Supplemental Table 2) [1].
    [Show full text]
  • Identification of Core Genes Involved in the Progression of Cervical
    International Journal of Molecular Sciences Article Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis Marina Dudea-Simon 1, Dan Mihu 1, Alexandru Irimie 2,3, Roxana Cojocneanu 4, Schuyler S. Korban 5, Radu Oprean 6, Cornelia Braicu 4,* and Ioana Berindan-Neagoe 4,7 1 2nd Obstetrics and Gynecology Department, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania; [email protected] (M.D.-S.); [email protected] (D.M.) 2 Department of Surgery, “Prof. Dr. Ion Chiricuta” Oncology Institute, 400015 Cluj-Napoca, Romania; [email protected] 3 Department of Surgical Oncology and Gynecological Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 4 Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 23 Marinescu Street, 400337 Cluj-Napoca, Romania; [email protected] (R.C.); [email protected] (I.B.-N.) 5 Department of Natural and Environmental Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA; [email protected] 6 Analytical Chemistry Department, Iuliu Hatieganu University of Medicine and Pharmacy, 4, Louis Pasteur Street, 400349 Cluj-Napoca, Romania; [email protected] 7 Department of Functional Genomics and Experimental Pathology, “Prof. Dr. Ion Chiricu¸tă” Oncology Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania * Correspondence: [email protected] Received: 5 September 2020; Accepted: 1 October 2020; Published: 3 October 2020 Abstract: In spite of being a preventable disease, cervical cancer (CC) remains at high incidence, and it has a significant mortality rate. Although hijacking of the host cellular pathway is fundamental for developing a better understanding of the human papillomavirus (HPV) pathogenesis, a major obstacle is identifying the central molecular targets involved in HPV-driven CC.
    [Show full text]
  • Novel Insights Into the Molecular Heterogeneity of Hepatocellular Carcinoma
    bioRxiv preprint doi: https://doi.org/10.1101/101766; this version posted January 19, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Novel insights into the molecular heterogeneity of hepatocellular carcinoma Running head: HCC molecular heterogeneity Juan Jovel1,5, Zhen Lin1,5, Sandra O’keefe1, Steven Willows1, Weiwei Wang1, Guangzhi Zhang1, Jordan Patterson1, David J. Kelvin4, Gane Ka-Shu Wong1,2,4, * and Andrew L. Mason1,* 1. Department of Medicine, University of Alberta. Edmonton AB, T6G 2E1, Canada 2. Department of Biological Sciences, University of Alberta, Edmonton AB, T6G 2E9, Canada 3. BGI-Shenzhen, Beishan Industrial Zone, Yantian District, Shenzhen 518083, China 4. Division of Experimental Therapeutics, University Health Network, Toronto, ON, M5G 1L7, Canada 5. These authors contributed equally to this work * Corresponding authors G.K. Wong 4-126 Katz Group Centre for Pharmacy and Health Research University of Alberta, Edmonton AB, T6G 2E1 [email protected] Phone 780 492 8663 Fax: 780 492 2475 A.L. Mason 7-142 Katz Group Centre for Pharmacy and Health Research University of Alberta, Edmonton AB, T6G 2E1 [email protected] Phone 780 492 8176 Fax: 780 492 1655 Competing interest: The authors declare that no competing interest exists This work was supported by funding from Alberta Innovates Technology Futures-Innovates Centres of Research Excellence (AITF-iCORE) to GKSW. bioRxiv preprint doi: https://doi.org/10.1101/101766; this version posted January 19, 2017.
    [Show full text]
  • Creating Reference Gene Annotation for the Mouse C57BL6/J Genome Assembly
    Mamm Genome (2015) 26:366–378 DOI 10.1007/s00335-015-9583-x Creating reference gene annotation for the mouse C57BL6/J genome assembly 1 1 Jonathan M. Mudge • Jennifer Harrow Received: 2 April 2015 / Accepted: 18 June 2015 / Published online: 18 July 2015 Ó The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Annotation on the reference genome of the of identifying and describing gene structures. However, in C57BL6/J mouse has been an ongoing project ever since the the 21st century, genes are increasingly regarded as col- draft genome was first published. Initially, the principle lections of distinct transcripts—generated, most obviously, focus was on the identification of all protein-coding genes, by alternative splicing—that can have biologically distinct although today the importance of describing long non-cod- roles (Gerstein et al. 2007). The process of ‘gene’ anno- ing RNAs, small RNAs, and pseudogenes is recognized. tation is therefore perhaps more accurately understood as Here, we describe the progress of the GENCODE mouse that of ‘transcript’ annotation (with separate consideration annotation project, which combines manual annotation from being given to pseudogene annotation). The information the HAVANA group with Ensembl computational annota- held in such models can be divided into two categories. tion, alongside experimental and in silico validation pipeli- Firstly, the model will contain the coordinates of the nes from other members of the consortium. We discuss the transcript structure, i.e., the coordinates of exon/intron more recent incorporation of next-generation sequencing architecture and splice sites, as well as the transcript start datasets into this workflow, including the usage of mass- site (TSS) and polyadenylation site (if known; see ‘‘The spectrometry data to potentially identify novel protein- incorporation of next-generation sequencing technologies coding genes.
    [Show full text]
  • Detection of H3k4me3 Identifies Neurohiv Signatures, Genomic
    viruses Article Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis Liana Basova 1, Alexander Lindsey 1, Anne Marie McGovern 1, Ronald J. Ellis 2 and Maria Cecilia Garibaldi Marcondes 1,* 1 San Diego Biomedical Research Institute, San Diego, CA 92121, USA; [email protected] (L.B.); [email protected] (A.L.); [email protected] (A.M.M.) 2 Departments of Neurosciences and Psychiatry, University of California San Diego, San Diego, CA 92103, USA; [email protected] * Correspondence: [email protected] Abstract: Human postmortem specimens are extremely valuable resources for investigating trans- lational hypotheses. Tissue repositories collect clinically assessed specimens from people with and without HIV, including age, viral load, treatments, substance use patterns and cognitive functions. One challenge is the limited number of specimens suitable for transcriptional studies, mainly due to poor RNA quality resulting from long postmortem intervals. We hypothesized that epigenomic Citation: Basova, L.; Lindsey, A.; signatures would be more stable than RNA for assessing global changes associated with outcomes McGovern, A.M.; Ellis, R.J.; of interest. We found that H3K27Ac or RNA Polymerase (Pol) were not consistently detected by Marcondes, M.C.G. Detection of H3K4me3 Identifies NeuroHIV Chromatin Immunoprecipitation (ChIP), while the enhancer H3K4me3 histone modification was Signatures, Genomic Effects of abundant and stable up to the 72 h postmortem. We tested our ability to use H3K4me3 in human Methamphetamine and Addiction prefrontal cortex from HIV+ individuals meeting criteria for methamphetamine use disorder or not Pathways in Postmortem HIV+ Brain (Meth +/−) which exhibited poor RNA quality and were not suitable for transcriptional profiling.
    [Show full text]
  • Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Fall 2010 Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Renuka Nayak University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Computational Biology Commons, and the Genomics Commons Recommended Citation Nayak, Renuka, "Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress" (2010). Publicly Accessible Penn Dissertations. 1559. https://repository.upenn.edu/edissertations/1559 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1559 For more information, please contact [email protected]. Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Abstract Genes interact in networks to orchestrate cellular processes. Here, we used coexpression networks based on natural variation in gene expression to study the functions and interactions of human genes. We asked how these networks change in response to stress. First, we studied human coexpression networks at baseline. We constructed networks by identifying correlations in expression levels of 8.9 million gene pairs in immortalized B cells from 295 individuals comprising three independent samples. The resulting networks allowed us to infer interactions between biological processes. We used the network to predict the functions of poorly-characterized human genes, and provided some experimental support. Examining genes implicated in disease, we found that IFIH1, a diabetes susceptibility gene, interacts with YES1, which affects glucose transport. Genes predisposing to the same diseases are clustered non-randomly in the network, suggesting that the network may be used to identify candidate genes that influence disease susceptibility.
    [Show full text]
  • 1 Deep Transcriptome Annotation Enables the Discovery and Functional 1 Characterization of Cryptic Small Proteins 2 3 4 Sondos S
    1 Deep transcriptome annotation enables the discovery and functional 2 characterization of cryptic small proteins 3 4 5 Sondos Samandi1,7†, Annie V. Roy1,7†, Vivian Delcourt1,7,8, Jean-François Lucier2, 6 Jules Gagnon2, Maxime C. Beaudoin1,7, Benoît Vanderperre1, Marc-André Breton1, Julie 7 Motard1,7, Jean-François Jacques1,7, Mylène Brunelle1,7, Isabelle Gagnon-Arsenault6,7, 8 Isabelle Fournier8, Aida Ouangraoua3, Darel J. Hunting4, Alan A. Cohen5, Christian R. 9 Landry6,7, Michelle S. Scott1, Xavier Roucou1,7* 10 11 1Department of Biochemistry, 2Department of Biology and Center for Computational 12 Science, 3Department of Computer Science, 4Department of Nuclear Medicine & 13 Radiobiology, 5Department of Family Medicine, Université de Sherbrooke, Québec, 14 Canada; 6Département de biologie, Département de biochimie, microbiologie et bio- 15 informatique and IBIS, Université Laval, Québec, Canada; 7PROTEO, Québec Network 16 for Research on Protein Function, Structure, and Engineering, Québec, Canada; 17 8Université Lille, INSERM U1192, Laboratoire Protéomique, Réponse Inflammatoire & 18 Spectrométrie de Masse (PRISM) F-59000 Lille, France 19 20 †These authors contributed equally to this work 21 *Correspondance to Xavier Roucou: Département de biochimie (Z8-2001), Faculté de 22 Médecine et des Sciences de la Santé, Université de Sherbrooke, 3201 Jean Mignault, 1 23 Sherbrooke, Québec J1E 4K8, Canada, Tel. (819) 821-8000x72240; Fax. (819) 820 6831; 24 E-Mail: [email protected] 25 26 Abstract 27 28 Recent functional, proteomic and ribosome profiling studies in eukaryotes have 29 concurrently demonstrated the translation of alternative open reading frames (altORFs) in 30 addition to annotated protein coding sequences (CDSs). We show that a large number of 31 small proteins could in fact be coded by these altORFs.
    [Show full text]
  • Identification and Interaction Analysis of Molecular Markers in Pancreatic
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.20.20248601; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatics Analysis and Molecular Docking Experiments Basavaraj Vastrad1 , Chanabasayya Vastrad *2, Anandkumar Tengli3 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics,Chanabasava Nilaya, Bharthinagar, Dharwad, Karanataka 580001, India. 3. Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru and JSS Academy of Higher Education & Research, Mysuru- 570015, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.20.20248601; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract The current investigation aimed to mine therapeutic molecular targets that play an key part in the advancement of pancreatic ductal adenocarcinoma (PDAC). The expression profiling by high throughput sequencing dataset profile GSE133684 dataset was downloaded from the Gene Expression Omnibus (GEO) database.
    [Show full text]
  • Genome-Wide Profiling of RNA Splicing in Prostate Tumor from RNA
    Srinivasan et al. Journal of Clinical Bioinformatics 2012, 2:21 JOURNAL OF http://www.jclinbioinformatics.com/content/2/1/21 CLINICAL BIOINFORMATICS METHODOLOGY Open Access Genome-wide Profiling of RNA splicing in prostate tumor from RNA-seq data using virtual microarrays Subhashini Srinivasan1*, Arun H Patil1, Mohit Verma1, Jonathan L Bingham2 and Raghunathan Srivatsan1 Abstract Background: Second generation RNA sequencing technology (RNA-seq) offers the potential to interrogate genome-wide differential RNA splicing in cancer. However, since short RNA reads spanning spliced junctions cannot be mapped contiguously onto to the chromosomes, there is a need for methods to profile splicing from RNA-seq data. Before the invent of RNA-seq technologies, microarrays containing probe sequences representing exon-exon junctions of known genes have been used to hybridize cellular RNAs for measuring context-specific differential splicing. Here, we extend this approach to detect tumor-specific splicing in prostate cancer from a RNA-seq dataset. Method: A database, SPEventH, representing probe sequences of under a million non-redundant splice events in human is created with exon-exon junctions of optimized length for use as virtual microarray. SPEventH is used to map tens of millions of reads from matched tumor-normal samples from ten individuals with prostate cancer. Differential counts of reads mapped to each event from tumor and matched normal is used to identify statistically significant tumor-specific splice events in prostate. Results: We find sixty-one (61) splice events that are differentially expressed with a p-value of less than 0.0001 and a fold change of greater than 1.5 in prostate tumor compared to the respective matched normal samples.
    [Show full text]